Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Lifevantage CorpLFVN · Entity 6941 | Director | November 06, 2025 | November 11, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Lifevantage Corp
Report date November 06, 2025 · Filed November 11, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 23,999 |
Reported balance
After 2025-11-06 transaction · row 1
1 source rowRow 1 · 2025-11-06 · Grant · Acquired 13,531 · Balance 23,999 F1: These shares were granted to the reporting person pursuant to the issuer's outside director compensation program and will vest in a single installment on November 6, 2026, subject to the reporting person's continuous service to the issuer through such date. F2: The price reported in Column 4 is equal to the weighted average closing price of the issuer's common stock for the ten trading days ending the day before the date of the grant. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were granted to the reporting person pursuant to the issuer's outside director compensation program and will vest in a single installment on November 6, 2026, subject to the reporting person's continuous service to the issuer through such date.
F2: The price reported in Column 4 is equal to the weighted average closing price of the issuer's common stock for the ten trading days ending the day before the date of the grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 06, 2025 Filed Nov 11, 2025 00:15 UTC | Lifevantage Corp LFVN · Entity 6941 | GrantCommon Stock | 13,531 | $7.76 | $105,000.56 |
DisclosureSEC source: 0001628280-25-051224 · wk-form4_1762820112.xml · nonDerivative · entry 1 Anbalagan Rajendran · CIK 0002033756 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,999 F1 · shares: These shares were granted to the reporting person pursuant to the issuer's outside director compensation program and will vest in a single installment on November 6, 2026, subject to the reporting person's continuous service to the issuer through such date. F2 · price: The price reported in Column 4 is equal to the weighted average closing price of the issuer's common stock for the ten trading days ending the day before the date of the grant. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 22:04 UTC | Lifevantage Corp LFVN · Entity 6941 | GrantCommon Stock | 7,819 | $13.43 | $105,009.17 |
DisclosureSEC source: 0000849146-24-000134 · wk-form4_1731449033.xml · nonDerivative · entry 1 Anbalagan Rajendran · CIK 0002033756 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,468 F1 · shares: These shares were granted to the reporting person pursuant to the issuer's outside director compensation program and will vest in a single installment on November 7, 2025, subject to the reporting person's continuous service to the issuer through such date. F2 · price: The price reported in Column 4 is equal to the weighted average closing price of the issuer's common stock for the ten trading days ending the day before the date of the grant. Read SEC document |
| August 26, 2024 Filed Aug 27, 2024 20:11 UTC | Lifevantage Corp LFVN · Entity 6941 | GrantCommon Stock | 2,649 | $8.26 | $21,880.74 |
DisclosureSEC source: 0000849146-24-000068 · wk-form4_1724789474.xml · nonDerivative · entry 1 Anbalagan Rajendran · CIK 0002033756 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,649 F1 · shares: These shares were granted to the reporting person pursuant to the issuer's outside director compensation program and will vest in a single installment on August 26, 2025, subject to the reporting person's continuous service to the issuer through such date. F2 · price: The price reported in Column 4 is equal to the weighted average closing price of the issuer's common stock for the ten trading days ending the day before the date of Mr. Anbalagan's election to the Board of Directors. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.